Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Choosing points over cash back can be beneficial in specific situations. Understand when to make that switch for better rewards.
27,195 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Bloom Energy has climbed about 160% ytd, powered by a surge in AI-related data-center demand and new partnerships. Th...
Looking for a higher yield consistent dividend or steady dividend growth? This in-depth guide compares VIG and FDVV, ...
A sharp 20% drop has many investors asking if PayPal stock is a bargain or a value trap. This guide breaks down the b...
TeraWulf (WULF) shares pull back 22% from their 52-week high, but the company’s expanding HPC footprint and Google-ba...
Qualcomm sits at the intersection of phones, cars, and AI tech. This guide breaks down what qualcomm stock investors ...
SpaceX is advancing toward an IPO in mid-June. This guide breaks down what the S-1 reveals, how to assess risk, and p...
Berkshire Hathaway kicked off the year with bold portfolio changes. In Q1, the company swapped key holdings and redir...
As military spending climbs worldwide, select defense stocks poised benefit due to diversified portfolios, strong cas...
Ford is tilting its model lineup toward affordability as CEO Jim Farley emphasizes simpler trims, hybrids, and scalab...
Celsius shares have fallen more than 50% from their intraday peaks as growth from newly acquired brands accelerates. ...
A $620,000 portfolio that pays may offer retirees a path to replace or supplement Social Security through dividend in...